Regina Martinez
Acute Care · Spring, TXNPI 1619724267
Payments from drug & device makers
Across 106 payments — averaging $26.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$377
- AbbVie$310
- Sobi, Inc$204
- AstraZeneca$187
- AVEO Pharmaceuticals, Inc.$185
- Amgen$150
- plus $1K from 33 others
What the payments were for
- Food & beverage$2,49287%
- Education$35713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 14 | $377 |
| AbbVie | 10 | $310 |
| Sobi, Inc | 5 | $204 |
| AstraZeneca(2 entities) | 5 | $187 |
| AVEO Pharmaceuticals, Inc. | 6 | $185 |
| Amgen | 8 | $150 |
| Merck | 6 | $148 |
| Lilly USA, LLC | 3 | $112 |
| Seagen Inc. | 1 | $75 |
| E.r. Squibb & Sons, L.L.C. | 4 | $72 |
| Genentech USA, Inc. | 3 | $69 |
| Novartis | 3 | $68 |
| Sanofi | 1 | $67 |
| Tersera Therapeutics LLC | 2 | $61 |
| Incyte Corporation | 3 | $60 |
| UCB, Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $55 |
| GSK | 3 | $51 |
| Bayer | 2 | $51 |
| Recordati_rare_diseases_inc. | 2 | $50 |
| Iovance Biotherapeutics, Inc. | 1 | $38 |
| Karyopharm Therapeutics Inc. | 2 | $36 |
| Bristol Myers Squibb | 1 | $30 |
| Caris MPI, Inc. | 1 | $29 |
| Spectrum Pharmaceuticals Inc. | 1 | $26 |
| Eisai Inc. | 1 | $26 |
| Geron Corporation | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $21 |
| Alvogen Inc | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| Taiho Oncology, Inc. | 1 | $19 |
| Agios Pharmaceuticals, Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $18 |
| Blueprint Medicines Corporation | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $14 |
How this compares
$2,849 in reported general payments places this provider in the 85th percentile of 2,323 acute care providers in Texas.
Other acute care in Spring
- Jennifer PilotteDallas$232K
- Christie MorrisonSan Antonio$225K
- Amanda BradleyDallas$85K
- Laura WilsonEl Paso$32K
- Kim HuynhCypress$29K
- Martha LibertyDallas$28K
- Afton DickersonHouston$27K
- Eleanor WeltgeHouston$25K
- Leslie GutierrezHouston$25K
- Bahia ElkamandSugar Land$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.